Peptide therapy went from the province of anti-aging clinics and bodybuilding forums to mainstream telehealth in the span of about three years. Platforms now offer prescribed peptide protocols for recovery, growth hormone optimization, fat loss, and healing — and the price range is wide.
Here is a practical guide to the major peptides, what each actually does, and what a legitimate telehealth prescription costs in 2026.
Sermorelin
What it is: A synthetic analog of growth hormone-releasing hormone (GHRH). It stimulates the pituitary gland to produce more of your own growth hormone — rather than injecting exogenous HGH directly.
What the evidence shows: Sermorelin has more clinical data than most peptides. It improves growth hormone levels, sleep quality, body composition, and recovery in studies. It is generally considered safer than direct HGH because it works through the body's own regulatory systems.
What it costs: $120–300/month via telehealth platforms. MYRNK charges $240/month for sermorelin. Strut Health charges $120. Most programs require labs first.
BPC-157 (Body Protection Compound)
What it is: A synthetic pentadecapeptide derived from a protein found in gastric juice. It has shown significant healing and anti-inflammatory effects in animal models.
What the evidence shows: Primarily animal research. BPC-157 shows remarkable results in rats — accelerated tendon healing, reduced inflammation, gut protection. Human trials are limited. It is not FDA-approved and is not a prescription drug in the traditional sense — it is compounded by 503A pharmacies.
What it costs: $100–250/month via telehealth. Most platforms offer injectable and oral (capsule) forms.
Ipamorelin/CJC-1295
What it is: A combination commonly prescribed together. Ipamorelin is a selective GH secretagogue. CJC-1295 is a GHRH analog with a longer half-life than sermorelin.
Used for: growth hormone optimization, fat loss, muscle retention, sleep improvement.
What it costs: $150–350/month for the combined protocol.
The legitimate vs. illegitimate distinction
The biggest risk in peptide therapy is not the peptides themselves — it is sourcing. Peptides ordered from research chemical vendors are not made under pharmaceutical-grade conditions, are not tested for purity, and are not subject to any quality controls. The platforms on ClinicLayer use licensed 503A compounding pharmacies with state board inspection requirements.
If you are considering peptide therapy, get it via a licensed telehealth platform with physician oversight and pharmacy documentation. The price premium over research vendor pricing is real, but the quality assurance difference is also real.